Direxion Daily Healthcare Bull 3X ETF (CURE): outlook, holdings and fees
Direxion Daily Healthcare Bull 3X ETF (CURE) is an exchange-traded fund and is managed by Direxion Funds. The expense ratio is 0.95% and the yield is 0.98%. The ten largest holdings are 14% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on CURE
| Last price | $165.14 (-1.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 48% |
| Likely 1-month range (50%) | $150.06 – $179.72 |
| Normal 1-day range (±1σ) | ±3.1% |
| Distribution yield | 0.98% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
CURE fund facts
| Issuer | Direxion Funds |
|---|---|
| Theme | Leveraged |
| Assets under management | $157M |
| Expense ratio | 0.95% |
| Number of holdings | 42 |
| Portfolio turnover | 0% |
| Inception | Jun 15, 2011 |
| Exchange | NYSE |
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.
CURE top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 3.64% |
| Johnson & Johnson JNJ | Healthcare | 2.31% |
| AbbVie Inc ABBV | Healthcare | 1.84% |
| Merck & Company Inc MRK | Healthcare | 1.37% |
| UnitedHealth Group Incorporated UNH | Healthcare | 1.31% |
| Thermo Fisher Scientific Inc TMO | Healthcare | 0.91% |
| Amgen Inc AMGN | Healthcare | 0.81% |
| Gilead Sciences Inc GILD | Healthcare | 0.66% |
| Abbott Laboratories ABT | Healthcare | 0.67% |
| Pfizer Inc PFE | Healthcare | 0.59% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
CURE sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
CURE returns and risk
| Year to date | +13.5% |
|---|---|
| 1 year | +38.1% |
| 3 years (annualised) | +12.3% |
| 5 years (annualised) | +5.0% |
| 10 years (annualised) | +16.2% |
| Volatility (3 years) | 42.2% |
| Sharpe ratio (3 years) | 0.43 |
Past returns do not guarantee future results.
CURE: frequently asked questions
What does CURE invest in?
Direxion Daily Healthcare Bull 3X ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (3.6%), Johnson & Johnson (2.3%), AbbVie Inc (1.8%), Merck & Company Inc (1.4%), UnitedHealth Group Incorporated (1.3%).
What is the CURE expense ratio?
0.95% a year: about $95.00 for every $10,000 invested.
What is the CURE dividend yield?
0.98%. ATLAS does not hold the exact distribution dates for ETFs.
Will CURE go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 48%, with a likely range (50%) of $150.06 to $179.72 from $165.14 today. It is a probability, not a prediction.
How has CURE performed?
Year to date +13.5%, one year +38.1%, three years +12.3% a year, five years +5.0% a year. Past returns do not guarantee future results.
Similar ETFs: Leveraged
Educational information, not investment advice. Disclaimer